NeuroMetrix Reports Publication of Study Demonstrating that NC-stat DPNCheck is Effective at Detecting Diabetic Peripheral Neuropathy

[Business Wire] – NeuroMetrix, Inc. , a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto. more

View todays social media effects on NURO

View the latest stocks trending across Twitter. Click to view dashboard

See who NeuroMetrix is hiring next, click here to view